Hypera S.A.
HYPE3
Rang in Aktien
#4245
Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical... Based in São Paulo, Brazil, Hypera S.A. is a prominent pharmaceutical enterprise. The company's comprehensive product line encompasses a wide array of prescription medications, featuring established brands such as Adacne, Celestamine, Cizax, Diprosone, and Emprol XR, among many others. Beyond prescription drugs, Hypera offers specialized dermo-cosmetics through its Mantecorp Skincare brand. Its consumer health division markets popular remedies like Apracur, Benegrip, Engov, and Estomazil. Additionally, Hypera provides nutritional and vitamin supplements, including well-known names such as Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal. The company also maintains a significant presence in the generic and similar medicines market, offering products under the Neo Química brand and common formulations like Ibuprofen, Paracetamol, and Omeprazole. The organization officially became Hypera S.A. in February 2018, having previously operated as Hypermarcas S.A.
Aktienkurs
$5.33
Marktkapitalisierung
$3.75B
Veränderung (1 Tag)
2.16%
Veränderung (1 Jahr)
25.26%
Land
BR
Handel Hypera S.A. (HYPE3)
Kategorie
Healthcare
Aktien-Split-Historie für Hypera S.A. (HYPE3)
Die Aktie Hypera S.A. (Symbol: HYPE3) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Oct 21, 2026 statt.
Eine HYPE3-Aktie, die vor dem Oct 21, 2026 gekauft wurde, entspricht heute 0 HYPE3-Aktien.
Der letzte Aktiensplit fand am Oct 21, 2026 statt.
Eine HYPE3-Aktie, die vor dem Oct 21, 2026 gekauft wurde, entspricht heute 0 HYPE3-Aktien.
Liste der Aktiensplits
| Jahr | Aktien-Split | Multiplikator | Kumulierter Multiplikator |
|---|---|---|---|
| Nicht genügend Daten für die angegebenen Daten. | |||
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
| Unternehmen | Anzahl der Aktiensplits | Kumulierter Multiplikator | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
